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Abstract
Differential DNA methylation defects of H19/IGF2 are associated with congenital growth dis-
orders characterized by opposite clinical pictures. Due to structural differences between
human and mouse, the mechanisms by which mutations of the H19/IGF2 Imprinting Control
region (IC1) result in these diseases are undefined. To address this issue, we previously
generated a mouse line carrying a humanized IC1 (hIC1) and now replaced the wildtype
with a mutant IC1 identified in the overgrowth-associated Beckwith-Wiedemann syndrome.
The new humanized mouse line shows pre/post-natal overgrowth on maternal transmission
and pre/post-natal undergrowth on paternal transmission of the mutation. The mutant hIC1
acquires abnormal methylation during development causing opposite H19/Igf2 imprinting
defects on maternal and paternal chromosomes. Differential and possibly mosaic Igf2
expression and imprinting is associated with asymmetric growth of bilateral organs. Further-
more, tissue-specific imprinting defects result in deficient liver- and placenta-derived Igf2 on
paternal transmission and excessive Igf2 in peripheral tissues on maternal transmission,
providing a possible molecular explanation for imprinting-associated and phenotypically
contrasting growth disorders.
Author summary
A humanized mouse line carrying a mutation of theH19/IGF2 imprinting control region
demonstrates how tissue-specific and mosaic imprinting alterations result in growth dis-
orders with opposite clinical pictures and asymmetric growth of bilateral organs.
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Introduction
Imprinted genes show monoallelic and parent-of-origin-dependent expression and play key
roles in the control of growth and development. In humans, altered expression of imprinted
genes is associated with Imprinting Disorders (IDs) that are characterized by growth, meta-
bolic and behavioural disturbances [1–2]. Most imprinted genes are organized in clusters, in
which their parental-specific expression is dependent on Imprinting Control Regions (ICRs).
ICRs correspond to 2–5 kb-long sequences with differential DNA methylation on their mater-
nal and paternal alleles. Parental-specific ICR methylation is acquired during gametogenesis
and maintained in the zygote and somatic cells throughout development despite extensive
demethylation occurring in the embryo before implantation and de novo methylation after
implantation [3]. An evolutionary conserved cluster of imprinted genes of about 1 Mbp is
located on human chromosome 11p15.5 and mouse distal chromosome 7. The cluster is orga-
nized in two functionally independent domains, each with its own ICR. In the telomeric
domain, theH19/IGF2 intergenic differentially methylated region (also known as and herein
termed Imprinting Center 1, IC1) controls the reciprocal imprinting of the maternally
expressedH19 and paternally expressed Insulin like Growth Factor 2 (IGF2) genes [3]. IGF2 is
required for normal foetal growth [4]. The liver is the main endocrine source of IGF2 in post-
natal life, but autocrine/paracrine activity is found in most embryonic tissues, particularly in
placenta, where it is needed for correct allocation of maternal resources to fetal growth [5, 6].
H19 is a long non-coding RNA with inhibitory activity on foetal growth [7]. Both IGF2/Igf2
andH19 are down-regulated after birth in both humans and mice but their deficiencies have
long-lasting effects on somatic growth [4, 7–11].
In mouse embryos,H19 and Igf2 are co-expressed in endoderm- and mesoderm-derived
tissues, and their expression depends on the same downstream enhancers on the maternal and
paternal chromosomes, respectively [12–15]. IC1 is structurally different in humans and mice
—human IC1 (hIC1) is * 5kb-long and contains seven CCCTC-binding factor (CTCF) target
sites (CTS), whereas mouse IC1 (mIC1) is * 2kb-long and contains four CTS (Fig 1A). CTCF
binding to IC1 is required for the formation of an insulator with enhancer blocking activity in
both species [16–17]. Because IC1 is methylated on the paternal allele and CTCF binding is
inhibited by DNA methylation, the insulator is formed only on the maternal chromosome
where it prevents the activation of IGF2 but allows activation ofH19 by the enhancers. The
opposite happens on the paternal chromosome, where IGF2 is activated andH19 silenced.
Opposite hIC1 methylation and imprinting defects are associated with the Beckwith-
Wiedemann syndrome (BWS, MIM #130650) and the Silver Russell syndrome (SRS, MIM
#180860), two IDs characterised by congenital overgrowth and congenital undergrowth,
respectively [1]. In particular, hIC1 gain of methylation (GOM) resulting in IGF2 activation
andH19 repression on the maternal chromosome is found in 5–10% of BWS cases. Con-
versely, hIC1 loss of methylation (LOM) leading to IGF2 repression andH19 activation on the
paternal chromosome occurs in about 50% of SRS patients. In a number of BWS cases with
hIC1 GOM, small deletions and single nucleotide variations within hIC1 co-segregate with the
clinical phenotype and abnormal methylation upon maternal transmission but lead to normal
phenotype on paternal transmission [11, 18–25]. Different paternally inherited hIC1 deletions
have been recently described in a few cases of SRS with IC1 LOM [26]. Although the extent of
these deletions is similar to those found in BWS families, the sequence and the CTSs involved
are different.
In the last twenty years, several mutations have been introduced into the endogenous mIC1
locus [27–35]. This work has been instrumental to demonstrate the fundamental role that
H19/IGF2 imprinting has in the aetiology of congenital overgrowth and undergrowth
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Fig 1. Strategy for generating the H19hIC1Δ2.2 allele. (A)Schematics of the endogenous mouseH19 locus, targeting vector for mutant hIC1
(pH19hIC1Δ2.2-neo), targeted mutant allele with the neomycin resistance cassette (H19hIC1Δ2.2-neo), targeted mutant allele after neoR excision (H19hIC1Δ2.2)
and targeted wildtype hIC1 allele (H19hIC1). Depicted are the IC1 (white rectangle) with CTCF binding sites (vertical lilac bars within IC1), ZFP57
binding sites (purple circles),H19 exons (gray rectangles); pBluescriptIIKS vector with the human insert flanked by the mouse sequences (outlined with
dashed blue lines) used as arms for the homologous recombination, neoR cassette (yellow rectangle), loxP sites (black arrowheads). Restriction sites and
their relative positions (in kb) to the 5’ end ofH19 are also indicated. Probes (A and B) used for Southern blot analysis are indicated as thick green lines
below the endogenous locus. Positions of the primers for testing the neo cassette excision are indicated by green arrows. Dashed green lines define the
A transgenic mouse model of BWS and SRS
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associated with imprinting defects. However, due to its structural differences with the ortholo-
gous mouse locus, the mechanism by which hIC1 mutations affect epigenotype and phenotype
in both BWS and SRS is still obscure.
To clarify the role of hIC1 mutations in the origin of imprinting defects and in the patho-
genesis of BWS and SRS, we generated a knock-in (KI) mouse line in which the endogenous
mIC1 was replaced by the orthologous hIC1 allele carrying a mutation (hIC1Δ2.2) that is asso-
ciated with BWS on maternal transmission [36]. We compared theH19hIC1Δ2.2 line with wild-
type mice and the previously described line carrying a humanized H19 allele with the wildtype
human ICR (H19hIC1) [37]. The results demonstrate growth and molecular abnormalities of
the mice with maternal and paternal transmission of the mutant KI that resemble those of
BWS and SRS, respectively, including asymmetric organ growth. Importantly, tissue-specific
and mosaic dysregulation ofH19/Igf2 imprinting indicates new pathogenetic mechanisms of
congenital growth disorders and lateralized/regional over/under-growth associated with
imprinting defects.
Results
Generation of the H19hIC1Δ2.2 and H19hIC1 lines
In order to study the relationship between genotype, epigenotype and phenotype of IDs in the
mouse, we replaced the endogenous mIC1 with a mutant hIC1 allele (H19hIC1Δ2.2) previously
found in BWS [19, 36], by homologous recombination in mouse embryonic stem (ES) cells
(Fig 1A). Chimeras were obtained and germ line transmission was confirmed by Southern
blotting (Fig 1B). The transgenic line was then bred to pCX-NLS- Cre transgenic line to
remove the NeoR cassette and its excision was confirmed by PCR (Fig 1C. See also Materials
and methods).
We crossed KI mice on a C56BL/6 (B6) background to Balb/C and used polymorphisms
present between these two strains to distinguish parental alleles. To compare the behaviour of
the mutant with that of the wildtype hIC1 allele (H19hIC1) in the same genetic background, the
previously described H19hIC1 line [37] was generated anew by targeting ES cells and breeding
the mice using similar procedures to what done with theH19hIC1Δ2.2 line. Subsequent experi-
ments were performed on both humanized KI lines. The wildtype +/+ littermates were also
assayed as control.
Maternal transmission of the H19hIC1Δ2.2 allele results in overgrowth and
tissue-specific Igf2 activation
Phenotypic analysis. To determine the consequence of maternal transmission of the
H19hIC1Δ2.2 allele on somatic growth, we measured the body weight of the F1 progeny of
H19hIC1Δ2.2/+XH19+/+ crosses from birth to 14 weeks of age. Compared to theirH19+/+ litter-
mates,H19hIC1Δ2.2/+ mice were significantly heavier, longer and larger at birth and overgrowth
persisted postnatally until adult age (Fig 2A and 2B). In addition, kidney and tongue but not
liver were significantly heavier in adultH19hIC1Δ2.2/+mice, if normalized to the weight of the
whole animal, indicating the presence of nephromegaly and macroglossia (Fig 2C). Consistent
region of hIC1 deleted in the hIC1Δ2.2 allele. (B) Southern blot analysis to confirm targeting of mutant hIC1 allele. DNA from wildtype (+/+) and
targeted (+/hIC1Δ2.2-neo) ES cells was digested with EcoRV and hybridized to probe A (lying 5’ of the targeting arm) or digested with StuI and
hybridized to probe B (lying 3’ of the targeting arm). (C) Confirmation of Cre-mediated excision of neoR cassette. Excision was confirmed by PCR with
primers (green arrows in fig 1A) flanking neoR. A PCR product of 550 bp confirming excision was obtained from genomic DNA of F1 (Cre/hIC1Δ2.2)
mice, and F2 (+/hIC1Δ2.2) derived from F1 crossed to wildtype mice. No PCR product was obtained from KI mice (+/hIC1Δ2.2-neo) with the NeoR
cassette.
https://doi.org/10.1371/journal.pgen.1007243.g001
A transgenic mouse model of BWS and SRS
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007243 February 22, 2018 4 / 23
with previously published data [37], no growth difference was observed betweenH19hIC1/+ and
H19+/+ mice (S1 Fig). Thus, in contrast toH19hIC1, maternal transmission ofH19hIC1Δ2.2 results
in congenital macrosomia and organomegaly that persist in the adulthood.
Molecular analysis. To examine expression and methylation of theH19/Igf2 locus upon
maternal transmission of the KI alleles, RNA and DNA were extracted from liver, kidney and
tongue of newborn (P1) mice. When measured by quantitative real-time PCR (RT-qPCR),
H19 RNA levels were significantly lower inH19hIC1Δ2.2/+mice compared with theirH19+/+ lit-
termates in all analyzed tissues, while levels of Igf2RNA were higher in tongue, but similar or
not significantly increased in liver and kidney (Fig 3A). Allele-specific RNA analysis revealed
Fig 2. Somatic overgrowth on maternal transmission of the H19hIC1Δ2.2 allele. Box plot of birth weights (A), growth
charts (B), and box plots of organ/whole animal weights at 14 weeks of age (C) ofH19hIC1Δ2.2/+ andH19+/+ littermates.
Box plots display the full range of variation (from minimum to maximum values), the likely range of variation (first and
third quartiles) and the median (horizontal bar within box). Values in brackets indicate the number of animals derived
from three litters that was used for this study. P = P-value calculated by two-tailed Student’s T-test. In (B) the growth
chart is expressed as ratio between the weights of KI and weights of +/+ animals in three litters. Bars represent the
mean ± SEM. In (C) the box plots represent the relative values of organ weight/whole animal weight ratios, obtained by
arbitrarily setting the median value ofH19+/+ as 1.
https://doi.org/10.1371/journal.pgen.1007243.g002
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that, while the imprinted H19 expression (paternal allele repressed) was normally maintained
in all tissues ofH19hIC1Δ2.2/+mice as well asH19+/+ littermates, the maternal Igf2 allele was
derepressed in tongue (44% mat/mat+pat expression) and kidney (31%) ofH19hIC1Δ2.2/+mice
(Fig 3B). In contrast, the relative expression (8%) of maternal Igf2 in liver ofH19hIC1Δ2.2/+ and
H19+/+ mice was comparable. Consistent with previous data [37], total expression levels and
imprinting of both H19 and Igf2 inH19hIC1/+ andH19+/+ mice were comparable (S2A and
S2B Fig).
In BWS, maternal transmission of IC1 mutations is associated with IC1 GOM [36]. To
investigate if this phenotype was reproduced in the mutant KI mice, we assayed the methyla-
tion of two different IC1 regions, CTS1 and CTS6, inH19hIC1Δ2.2/+ andH19hIC1/+ mice, by
pyrosequencing of bisulfite-converted DNA. The results demonstrated that in contrast with
H19hIC1 that maintained very low (1–4%) methylation levels (Fig 4A and Ref. 37),H19hIC1Δ2.2
was aberrantly methylated at similar levels (62–75% in CTS1 and 55–58% in CTS6) in liver,
kidney and tongue. As expected, the endogenous paternal mIC1 was fully methylated and
the maternal mIC1 was unmethylated. Hypermethylation ofH19hIC1Δ2.2 was confirmed by
bisulfite sequencing. (Fig 4B). This assay shows complete methylation of 7 out of 15 molecules
Fig 3. Analysis of H19 and Igf2 expression in H19hIC1Δ2.2/+ newborn mice. (A) Histograms of totalH19 and Igf2 expression in three different neonatal
organs ofH19hIC1Δ2.2/+ andH19+/+ littermates analysed by RT-qPCR. The mean value ofH19+/+ is set arbitrarily as 1. NS, Not Significant. Bars
represent the mean ± SEM. (B) Allele-specific expression ofH19 and Igf2. Dots indicate the percent expression of the maternal allele in each individual
sample. The animals used for this study derived from three litters.
https://doi.org/10.1371/journal.pgen.1007243.g003
A transgenic mouse model of BWS and SRS
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Fig 4. Gain of IC1 methylation in H19hIC1Δ2.2/+ mice. (A) Graph representing the humanized and endogenousH19/
Igf2 locus with the regions (indicated by black bars) whose methylation was analysed by pyrosequencing. The region
deleted inH19hIC1Δ2.2 is represented by a shaded light blue box. The coordinates of the sequenced CpGs are: CTS1 in
hg39—chr11:2,024,193–2,024,261; CTS6 in hg39—chr11:2,021,096–2,021,153; mIC1 in mm9—chr7:149,767,625–
149,767,705; mIC2 in mm9—chr7:150,482,365–150,482,486. Other details are described in the legend to Fig 1. (B)
A transgenic mouse model of BWS and SRS
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indicating epigenetic mosaicism. Methylation analysis was repeated in three consecutive gen-
erations ofH19hIC1Δ2.2/+mice with consistent results (S3 Fig).
In summary, H19hIC1Δ2.2 exhibits aberrant hIC1 methylation upon maternal transmission
and is associated with abnormalH19 repression and tissue-specific Igf2 activation.
Paternal transmission of the H19hIC1Δ2.2 allele results in growth restriction
and tissue-specific Igf2 repression
Phenotypic analysis. We next assessed the effect of paternal transmission of the
H19hIC1Δ2.2 allele. Paternal transmission ofH19hIC1 resulted in embryonic lethality, confirming
our previous data [37]. In contrast, the F1 progeny of heterozygous H19hIC1Δ2.2 males bred to
H19+/+ females presented H19+/+ and KI pups in 1:1 ratio. However, compared with their
H19+/+ littermates, H19+/hIC1Δ2.2mice weighed less and were smaller at birth and maintained
growth restriction postnatally until adult age (Fig 5A and 5B).H19+/hIC1Δ2.2mice also appeared
very lean and the weight of their liver and tongue, normalized to that of the whole animal, was
significantly lower than that ofH19+/+ mice (Fig 5C).
To compare the effects of paternal transmission ofH19hIC1 andH19hIC1Δ2.2 on somatic
growth, we collected the embryos at a stage (E15.5) preceding the death ofH19+/hIC1 mice in
utero. Body and placenta of embryos from both KI strains were smaller thanH19+/+ litter-
mates. However, H19+/hIC1 embryos were even smaller (30% lighter thanH19+/+ littermates)
thanH19+/hIC1Δ2.2 embryos (13% lighter thanH19+/+ littermates) (Fig 5D). A more dramatic
difference was found in the placental weights (Fig 5E,H19+/hIC1 line *30% lighter than
H19+/+ littermates; H19+/hIC1Δ2.2 line *8% lighter thanH19+/+ littermates).
Thus, although paternal transmission of bothH19hIC1 andH19hIC1Δ2.2 results in growth
restriction, the phenotype ofH19+/hIC1Δ2.2 is less severe than that ofH19+/hIC1 embryos and is
compatible with life.
Molecular analysis. Gene expression and DNA methylation at theH19/Igf2 locus were
measured in liver, kidney and tongue of P1H19+/hIC1Δ2.2 and H19+/+ littermates. TotalH19
expression was significantly increased in tongue, while Igf2 levels were severely decreased in
liver and more moderately in kidney ofH19+/hIC1Δ2.2 mice (Fig 6A). Analysis of allele-specific
expression revealed that inH19+/hIC1Δ2.2 mice the paternalH19 allele was strongly derepressed
in liver (44% pat/mat+pat expression) and more moderately in tongue (15%, see Fig 6B). In
kidney, the relative expression of the paternalH19 allele (8%) was comparable to that of
H19+/+ mice. The imprinted Igf2 expression (maternal allele repressed) was properly main-
tained in all three tissues inH19+/hIC1Δ2.2 as well as theirH19+/+ littermates (Fig 6B).
To compare H19/Igf2 expression ofH19+/hIC1Δ2.2 and H19+/hIC1, E15.5 conceptuses were
also analysed. TotalH19 expression was increased about 2-fold in embryo body and placenta
ofH19+/hIC1, butH19 activation was less evident and did not reach statistical significance in
Percent methylation measured by pyrosequencing at two CTCF target sites (CTS1 and CTS6) in three different organs
collected fromH19hIC1Δ2.2/+ andH19hIC1/+ mice at birth (left panel). Endogenous mIC1 analysed as control of
methylation: the paternal allele (pat) was assayed inH19hIC1Δ2.2/+, the maternal allele (mat) inH19+/hIC1Δ2.2, and both
alleles (pat + mat) inH19+/+ mice (right panel). Each histogram represents the methylation mean value of 5 (CTS1 and
mIC1) or 6 (CTS6) CpGs, tested inH19hIC1Δ2.2/+ (n = 10),H19hIC1/+ (n = 9) andH19+/+ (n = 7) mice derived from
three litters. Bars represent the mean ± SEM. Note that methylation (ranging from 55% to 75%) was observed at the
H19hIC1Δ2.2 and not at theH19hIC1 allele. (C) IC1 methylation analysed by bisulphite treatment followed by cloning and
sequencing in tongue ofH19hIC1/+ andH19hIC1Δ2.2/+mice. Each line corresponds to a single template DNA molecule
cloned; each circle corresponds to a CpG dinucleotide. Filled circles designate methylated cytosines; open circles,
unmethylated cytosines. CpGs measured by pyrosequencing are framed.
https://doi.org/10.1371/journal.pgen.1007243.g004
A transgenic mouse model of BWS and SRS
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007243 February 22, 2018 8 / 23
Fig 5. Somatic undergrowth on paternal transmission of the H19hIC1Δ2.2 allele. (A-C) Box plot of birth weights (A), growth
charts (B), and box plots of organ weights at 14 weeks of age (C) ofH19+/hIC1Δ2.2 andH19+/+ littermates. Box plots in (A) and
(C) and growth chart in (B) are as in Fig 2. (D-E) Box plot of embryo body and placenta weights ofH19+/hIC1Δ2.2 (D) and
H19+/hIC1 (E) mice at E15.5 compared withH19+/+ littermates. The animals used for this study derived from three (A-C) or two
litters (D-E).
https://doi.org/10.1371/journal.pgen.1007243.g005
A transgenic mouse model of BWS and SRS
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H19+/hIC1Δ2.2. In contrast, Igf2 expression was downregulated in embryo and placenta of both
KI lines, although repression in embryos was less dramatic inH19+/hIC1Δ2.2 than inH19+/hIC1
mice (S4A and S4B Fig). Allele-specific RNA analysis demonstrated that the paternalH19 allele
was strongly activated (close to 50% of total expression) in both embryo body and placenta
of E15.5H19+/hIC1, but only to a lower extent (25% in embryo body and 35% in placenta) in
H19+/hIC1Δ2.2. The imprinted Igf2 expression was properly maintained in bothH19+/hIC1 and
H19+/hIC1Δ2.2 (S4C and S4D Fig and Ref. 37).
We then measured IC1 methylation inH19+/hIC1Δ2.2 andH19+/hIC1 mice at E15.5 by pyrose-
quencing. In contrast with the extremely low (2–3%) methylation ofH19hIC1, theH19hIC1Δ2.2
allele was found partially (35–43%) methylated in both embryo body and placenta (Fig 7A).
Bisulfite-sequencing confirmed the differential methylation of theH19hIC1Δ2.2 andH19hIC1
alleles (Fig 7B). The analysis of liver, kidney and tongue of P1 mice demonstrated that methyl-
ation of theH19hIC1Δ2.2 allele was maintained postnatally. Methylation levels (64–77%) were
similar in these three adult tissues. They were higher than in embryonic tissues, but still lower
than the endogenous paternal mIC1 allele that was fully methylated (S5A and S5B Fig). Meth-
ylation analysis was repeated in three consecutive generations of KI mice derived from
Fig 6. Analysis of H19 and Igf2 expression in H19+/hIC1Δ2.2 newborn mice. (A) Histograms of totalH19 and Igf2 expression in three different neonatal
organs ofH19+/hIC1Δ2.2 andH19+/+ littermates analysed by RT-qPCR. The mean value ofH19+/+ is set arbitrarily as 1. NS, Not Significant. Bars
represent the mean ± SEM. (B) Dots indicate the percent expression of the paternal allele in each individual sample. The animals used for this study
derived from three litters.
https://doi.org/10.1371/journal.pgen.1007243.g006
A transgenic mouse model of BWS and SRS
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Fig 7. IC1 methylation in H19+/hIC1Δ2.2 and H19+/hIC1 mice at E15.5. (A) See legend to Fig 4A. (B) Percent
methylation measured by pyrosequencing at two CTCF target sites (CTS1 and CTS6) from embryo body and placenta
ofH19+/hIC1Δ2.2 andH19+/hIC1 mice at E15.5 (left panel). The endogenous mIC1 was analysed as in Fig 4. Each
histogram represents the methylation mean value of 5 (CTS1 and mIC1) or 6 (CTS6) CpGs, tested in two litters of each
KI: +/hIC1Δ2.2 (n = 6), +/+ (n = 5); +/hIC1 (n = 6) and +/+ (n = 4) embryos. Bars represent the mean ± SEM. (C) IC1
A transgenic mouse model of BWS and SRS
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breeding ofH19+/hIC1Δ2.2males with +/+ females with consistent results (S6A Fig). Also, meth-
ylation of the hIC1Δ2.2 allele did not change after the passage from the female to male germ-
line, as demonstrated by the methylation values of mice of two consecutive generations
derived from reciprocal breeding (S6B Fig).
In summary, paternal transmission ofH19hIC1Δ2.2 results in IC1 hypomethylation that is
less severe than that ofH19hIC1 and is associated with an imprinting defect on the paternal
chromosome causing moderateH19 activation accompanied by Igf2 repression that is particu-
larly prominent in liver and placenta.
Differential Igf2 expression and imprinting is associated with kidney
asymmetry in mutant KI mice
To investigate the presence of kidney asymmetry, a clinical sign often found in BWS [2], we
measured the weight of left and right kidneys of the mice carrying the mutant KI. Maternal
transmission was first assessed. A significant difference between the two kidneys (with no bias
toward the left or right organ) was found in adult and newbornH19hIC1Δ2.2/+ mice, but not in
H19+/+ littermates (Fig 8A and 8B). In contrast, no difference was observed inH19hIC1/+ mice
(S7 Fig). hIC1 methylation andH19/Igf2 expression were then assessed in the organs of the
neonates carrying the mutant KI. While DNA methylation andH19 expression were compara-
ble (Fig 8C and 8D), significant differences of total and allele-specific expression of Igf2were
found between the heavier and lighter kidneys ofH19hIC1Δ2.2/+ (with higher expression in the
larger organ) mice (Fig 8E and 8F). Next, we investigated the presence of kidney asymmetry in
the mice with paternal transmission of the KI. As for maternal transmission, weight differences
between the two kidneys inH19+/hIC1Δ2.2mice were significantly higher than in theirH19+/+
littermates, both at neonatal and adult stages (Fig 8G and 8H). Also, comparable hIC1 methyl-
ation and globalH19 RNA levels were found in left and right kidneys of all tested animals (Fig
8I and 8J). In contrast, paternalH19 expression was relatively more up-regulated in the lighter
kidneys of theH19+/hIC1Δ2.2mice (Fig 8K). Although not statistically significant (P<0.1), a
trend toward stronger Igf2 repression was observed in the smaller with respect to the larger
kidney (Fig 8I).
Low methylation of H19hIC1Δ2.2 in germ cells
Having demonstrated thatH19hIC1Δ2.2 is methylated in somatic cells upon both maternal and
paternal transmission, we asked if methylation was already present in germ cells. For this pur-
pose, we measured DNA methylation levels in oocytes and sperm by pyrosequencing. As
previously demonstrated, H19hIC1 remains properly hypomethylated in female gametes but
methylation is inefficiently established onH19hIC1 in male gametes (Fig 9A and Ref. 37). Simi-
larly,H19hIC1Δ2.2 methylation was close to 0% and comparable with the endogenous mIC1 in
oocytes (Fig 9A). mIC2 was also analysed as control and to rule out contamination of somatic
cells. The expected methylation value close to 100% was found inH19hIC1Δ2.2/+,H19hIC1/+ and
H19+/+ oocytes.
In sperm, methylation levels were relatively low (10–14%) onH19hIC1Δ2.2 as well asH19hIC1
(7–22%), while the endogenous mIC1 was almost 100% methylated (Fig 9A). The endogenous
mIC2, analysed as control, was correctly unmethylated in all three lines (H19hIC1Δ2.2/+,
methylation analysed by bisulphite treatment followed by cloning and sequencing in embryo body and placenta of
H19+/hIC1Δ2.2 andH19+/hIC1 mice at E15.5. See legend to Fig 4 for more details.
https://doi.org/10.1371/journal.pgen.1007243.g007
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Fig 8. Kidney asymmetry and H19/Igf2expression and imprinting on maternal and paternal transmission of the
H19+/hIC1Δ2.2 allele. (A-F) Analysis of maternal transmission. Weight difference of the kidneys at 12 weeks of age (A),
kidney weights at birth (B), DNA methylation level of CTS1 (C), totalH19 expression (D), allele-specific Igf2 expression
(E), and total Igf2 expression (F) in heavier and lighter kidneys ofH19hIC1Δ2.2/+ andH19+/+ mice. (G-L) Analysis of
paternal transmission. Weight difference of the kidneys at 12 weeks of age (G), kidney weights at birth (H), DNA
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H19hIC1/+ andH19+/+). The low methylation status ofH19hIC1Δ2.2 was confirmed by bisulphite
sequencing, in both oocytes and sperm (Fig 9B).
Overall, these results demonstrate that while DNA methylation of mutant hIC1 is normally
absent in oocytes, methylation is not efficiently established on the mutant KI as well as the
methylation level of CTS1 (I), totalH19 expression (J), allele-specificH19 expression (K), and total Igf2 expression (L)
analysed in heavier and lighter kidneys ofH19+/hIC1Δ2.2 andH19+/+ mice. Bars in A and G represent the mean ± SEM. Bars
in C-F and I-L represent the mean ± SEM of three technical replicates of the same sample. P-value calculated by two-tailed
Student’s T-test on lighter vs heavier kidneys of littermates with the same genotype. The animals used for this study
derived from two litters. Note that differences in weight, Igf2 expression andH19/Igf2 imprinting were present only in
mice carrying theH19hIC1Δ2.2 allele.
https://doi.org/10.1371/journal.pgen.1007243.g008
Fig 9. IC1 methylation in germ cells. (A) Percent methylation measured by pyrosequencing at CTS1 and CTS6 of hIC1 in oocytes and sperm of
H19hIC1Δ2.2/+ andH19hIC1/+ mice (left panel). Endogenous mIC1 (middle panel) and mIC2 (right panel) were analysed as controls of the methylation
assay and to rule out contamination of somatic cells. As expected, mIC1 was unmethylated in oocytes and fully methylated in sperm, and viceversa
mIC2 was fully methylated in oocytes and unmethylated in sperm, in all tested mouse lines. Each histogram represents the methylation mean value of 5
(CTS1, mIC1 and mIC2) or 6 (CTS6) CpGs, tested in a pool of germ cells collected from 4–5 females and 2 males. Bars represent the mean ± SEM. (B)
IC1 methylation analysed by bisulphite treatment followed by cloning and sequencing in oocytes and sperm ofH19hIC1Δ2.2/+mice.
https://doi.org/10.1371/journal.pgen.1007243.g009
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wildtype KI in male germ cells, indicating that paternal hypomethylation of theH19hIC1Δ2.2
allele is seemingly acquired as early as germline development and persists into embryo
development, while maternal hypermethylation of hIC1Δ2.2 alleles does not occur until after
fertilization.
Discussion
Gain and loss of IC1 methylation result inH19/IGF2 imprinting defects that are characteristic
of BWS and SRS, respectively. In some patients, genetic mutations have been found associated
with DNA methylation abnormalities in cis. However, the mechanism by which the genotype
affects the epigenotype and phenotype in these cases is unknown. By employing a KI mouse
line, this study demonstrates that a human genetic IC1 mutation reproduces several molecular
and phenotypic abnormalities of BWS and SRS. The analysis of this mouse model provides
mechanistic insights into the origin of prenatal overgrowth and undergrowth associated with
H19/Igf2 imprinting defects, which are useful for understanding the aetiopathogenesis of BWS
and SRS.
We have previously demonstrated that maternal transmission of hIC1 can functionally
replace mIC1 in the mouse by properly regulating IC1 methylation andH19/Igf2 imprinting
[37]. We now observe that mice maternally inheriting the mutant KI allele acquire methylation
on hIC1Δ2.2 after fertilization, exhibitH19 repression and biallelic Igf2 activation, and pre-
and post-natal overgrowth. Upon paternal transmission, hIC1 lacks methylation resulting in
complete Igf2 silencing, H19 activation, severe growth restriction particularly in placenta and
embryonic lethality [37]. In contrast, paternal hIC1Δ2.2 is partially methylated and results in a
more moderate imprinting defect and pre/post-natal undergrowth which is compatible with
life.
Methylation is established only in a minority of male germ cells on both hIC1Δ2.2 and
hIC1 and appears unstable indicating evolutionarily divergent mechanisms of imprinting
establishment between human and mouse [37]. However, while hIC1 is completely unmethy-
lated, hIC1Δ2.2 shows partial methylation on both paternal and maternal chromosomes in
embryo and placenta. Thus, methylation is likely acquired de novo and in mosaic form on
hIC1Δ2.2 in somatic cells, during development. The functional difference between hIC1Δ2.2
and hIC1 is likely due to the lack of three CTSs in the mutant allele, which shows lower affinity
for CTCF in human cells [36]. The results are consistent with hIC1 having an intrinsic propen-
sity to acquire methylation that is inhibited by CTCF binding [32]. The different behaviour of
hIC1Δ2.2 and mIC1, which share a similar number of CTSs (4) and ZFP57 binding sites (6),
suggests that the CTSs alone are not sufficient to maintain insulator function and that CTS
spacing or other transcription factor binding sites contribute to IC1 function. It is possible that
one or more of these elements are reduced or missing and this exposes the mutant hIC1 allele
to the action of de novo DNA methyl-transferases in pre- and/or post-implantation embryos.
The mechanisms by which hIC1 methylation is altered in BWS and SRS are unknown. Our
mouse model indicates that the maternal hIC1Δ2.2 methylation is acquired post-zygotically in
BWS, but does not allow to distinguish if the partial IC1 methylation of SRS is due to a primary
germ cell imprint establishment defect, or a post-zygotic maintenance defect, or both. How-
ever, the observation that the hIC1 methylation status can drastically change from gametes
to somatic cells, suggests that maintenance mechanisms have a critical role in the origin of
imprinting defects on both maternal and paternal chromosomes.
Molecular analyses show that, although hIC1Δ2.2 is similarly methylated in neonatal liver,
kidney and tongue, allele-specific H19/Igf2 expression is differently altered, suggesting that
hIC1 enhancer blocking function is regulated in a tissue-specific manner (Fig 10), consistent
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with what was previously shown for mIC1 [35]. In particular, the insulator activity of
hIC1Δ2.2 appears to be robust in liver and placenta, as demonstrated by weak expression of
the Igf2 allele in ciswith the KI. In contrast, the relatively high Igf2 expression indicates that
the insulator activity of hIC1Δ2.2 is weak in tongue. The kidney shows intermediate and
mosaic insulator activity resulting in differential Igf2 expression between left and right organs
Fig 10. Diagram summarizing the tissue-specific imprinting defects of the H19hIC1Δ2.2 mice. White rectangles represent the Igf2 and
H19 genes, grey rectangle mIC1 and green rectangles hIC1Δ2.2. Enhancers are indicated by green ovals. Transcription direction is
indicated by arrows and transcription intensity by arrow thickness. Lollipops indicate CTS methylation status: filled lollipops, methylated
CTSs; open lollipops: non-methylated CTSs; half-filled lollipops: partially methylated CTSs; dashed lollipops: missing CTSs in the deleted
region of hIC1Δ2.2. Curved arrows indicate Igf2 activation by downstream enhancers: arrow thickness is inversely proportional to the
insulator strength inferred from allele-specific Igf2 expression in each specific tissue. P: paternal chromosome; M: maternal chromosome.
https://doi.org/10.1371/journal.pgen.1007243.g010
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(see below). Tissue-specific differences in insulator activity may result from different post-
translational modifications of CTCF [35]. Importantly, the observation that Igf2 expression is
properly regulated in specific tissue contexts in the presence of abnormal IC1 methylation
paves the way to new exciting avenues for BWS and SRS therapy. Concerning H19, this gene is
significantly down-regulated in all three tissues ofH19hIC1Δ2.2/+ mice and up-regulated in liver
and tongue ofH19+/hIC1Δ2.2 mice, with respect to wildtype littermates, consistent with the par-
tial methylation of hIC1Δ2.2 and the demonstrated repressor activity of methylated IC1 [32].
In liver ofH19+/hIC1Δ2.2 neonates, a strong derepression of the imprinted allele was not accom-
panied by a global (mat + pat) increase of theH19 RNA, possibly because of other physiologi-
cal perturbations limiting its expression.
Overall, gene expression results are consistent with the hypothesis that the organomegaly
ofH19hIC1Δ2.2/+mice is associated with autocrine/paracrine effects of IGF2, while defective
hepatic and placental IGF2 expression underlie the growth restriction ofH19+/hIC1Δ2.2 mice.
Opposite deregulation of the growth inhibitory H19 transcript is likely playing an additional
role in the growth abnormalities of the mice with maternal and paternal transmission of the
mutant KI.
Although in humans this mutation is associated only with BWS, the hIC1Δ2.2 mice
display several features of BWS and SRS, on maternal and paternal transmission of the KI,
respectively. Growth abnormalities originate prenatally and persist in adulthood. In
particular, H19+/hIC1Δ2.2 mice do not catch-up growth during development, as seen in the
majority of children with SRS [38]. In addition, nephromegaly and macroglossia that are
observed in H19hIC1Δ2.2/+ mice are also distinctive clinical signs of BWS with IC1 molecular
defects [39]. Finally, the tissue-specific differences of hIC1 function we observed in the
mouse may explain some of the aetiopathogenetic mechanisms of BWS and SRS. The model
we propose predicts that maternal IC1 GOM in BWS causes IGF2 activation primarily in
peripheral tissues, such as tongue and kidney resulting in macroglossia and organomegaly,
while paternal IC1 LOM in SRS causes IGF2 repression primarily in liver and placenta lead-
ing to deficient growth stimulation through defective endocrine secretion and placenta
function.
BothH19hIC1Δ2.2/+ andH19+/hIC1Δ2.2mice show differential growth of the kidneys indicating
that asymmetric growth of bilateral organs occurs in these animals, as in many cases of BWS
with IC1 defects [40]. Derepression of the maternal Igf2 allele and repression of the paternal
Igf2 allele are incomplete in the kidney of P1H19hIC1Δ2.2/+ and P1H19+/hIC1Δ2.2mice, respec-
tively (see Figs 3 and 6), indicating mosaic expression ofH19/Igf2 in these tissues. Further anal-
yses showed that, although IC1 methylation and H19 RNA levels were similar, Igf2 expression
was higher in the larger than in the smaller kidney due to imprinting defects, indicating that
Igf2 is mostly responsible for the asymmetric kidney growth. These results raise the hypothesis
that mosaic IGF2 expression may also cause lateralized somatic overgrowth in humans. Our
results are consistent with the findings of Ginart et al [41] demonstrating that the incomplete
derepression of the paternalH19 allele in mutant mice can result from an epigenetic mosai-
cism at a single cell level.
Overall, our findings show that a mutant human IC1 sequence can reproduce the opposite
growth and molecular phenotypes of BWS and SRS in mouse, when introduced at the ortholo-
gous locus. Several mouse lines carrying mutations in theH19/Igf2 locus have been described
so far. Some of these mice, including a 1.3 kb deletion of mIC1 (Δ2,3) that results in tissue-spe-
cific loss of Igf2 imprinting, show similarities with ourH19hIC1Δ2.2 model [28, 34–35]. How-
ever, the methylation defects, growth abnormalities andH19/Igf2dysregulation ofH19hIC1Δ2.2
more closely reproduce the phenotypic features and contribute better in understanding the
molecular pathogenesis of BWS and SRS. Such humanized mouse models will be useful for
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more accurately unravelling pathogenetic mechanisms and for developing new therapeutic
strategies in these rare congenital growth disorders.
Materials and methods
Targeting of the mIC1 locus and generation of the KI mice
To generate theH19hIC Δ2.2 mouse line, we performed gene targeting by homologous recombi-
nation in E14 embryonic stem (ES) cells [42] to target the endogenous mIC1 with a plasmid
containing theH19hIC1Δ2.2 allele and neomycin resistance cassette (NeoR; Fig 1A). Briefly, a
PciI–MluI restriction fragment of 620 bp spanning the break-point of the 2.2 kb deletion
found in a BWS family [18] was extracted from the EΔ2.2 (B5/b1)pL vector [36] and subcloned
in the Δ3.8kb-5’ pre-targeting vector containing the wildtype hIC1 region [28]. Sanger
sequencing of the fragment was performed and no variant was found in respect to the refer-
ence human genome hg19. The subsequent steps to obtain the targeting vector were performed
as previously described [37]. To compare H19hIC1 and H19hIC1Δ2.2 in the same strain back-
ground and avoid animal transfer from US to Italy, the hIC1 KI line was generated anew by
performing gene targeting in E14 ES cells with the original vector used in the previous study
[37].
Injection into B6 blastocysts of theH19hIC1-neo andH19hIC1Δ2.2-neo KI ES clones and genera-
tion of chimeras were performed by Cogentech Facility S.c.a.r.l. (Milan, Italy). Chimeras were
crossed to B6 mice and germline transmission of the KI was confirmed in the agouti progeny
by PCR-genotyping using primers flanking the deletion break point (hDMDB5SeqF: 5’–GGT
AGTGAGGGATAGAACAC– 3’; hDMDB1RepR: 5’–GAGTGTCCTATTCCCAGATGAC–
3’) (Fig 1B). The NeoR cassette was excised by crossing heterozygous KI with pCX-NLS- Cre
transgenic mice [43] on a B6 background. Excision was tested by PCR using primers flanking
the NeoR cassette (NeoEXL3: 5’–ACAGAATCGGTTGTGGCTGT– 3’ H19SeqR1: 5’–CCACA
GAGTCAGCATCCAC– 3’) (Fig 1C). KI mice without the NeoR cassette were crossed with B6
mice and only the progeny carrying the KI and lacking the Cre gene were selected to expand
and assay the KI lines. All animal experimentation was conducted in accordance with the
guidelines of the Animal Care and Use Committee of Campania University “Luigi Vanvitelli”
(Naples, Italy) and was authorized by the Italian Ministry of Health.
Extraction of nucleic acids
Liver, kidneys and tongue were collected from mice at birth and at 14 weeks of age. Placenta
and whole body excluding the head were recovered from conceptuses of 15.5 days post coitum
(E15.5). Genomic DNA was isolated from tissues following the standard protocol of proteinase
K digestion and phenol-chloroform extraction. Total RNA was extracted using TRI Reagent
(Sigma-Aldrich Italia, Milan) and following the manufacturer’s protocol. Concentrations of
nucleic acids were determined with Nanodrop spectrophotometer. Sperm was isolated from
adult mice and DNA was extracted as described previously [44]. Unfertilized oocytes were col-
lected from 4–5 superovulated females of 8 weeks and resuspended in 0.03% SDS, 10 mg glyco-
gen, 10 mg proteinase K and 1 x PBS to a final volume of 20μl. Suspension was incubated at
37˚C for 90 min followed by 15 min at 95˚C before sodium bisulphite treatment for DNA
methylation analysis (see below).
Gene expression analysis
About 1 μg of total RNA was treated with RNase-free DNase, and first-strand cDNA was syn-
thesized using the QuantiTech Reverse Transcription Kit (Qiagen Italy, Milan), according to
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the manufacturer’s protocol. Total expression ofH19 and Igf2was measured by SYBR Green
quantitative real-time RT-PCR (Applied Biosystems Italy, Milan). Reactions were set up in
triplicate and run on ABI PRISM 7500 using the default cycling conditions. Relative expression
was determined using the ΔΔCT method, and the gene expression values were normalized to
the expression of the Gapdh, Arpp0 and beta-actin reference genes. Primer sequences are avail-
able on request. Allele-specific expression analysis was performed by typing for the polymor-
phisms present in the F1 progeny between the C57BL/6 (B6) and Balb/C mouse strains. The
MspI Restriction Fragment Length Polymorphism (RFLP) ofH19 (GRCm38/mm10 chr
7:142,577,609; sequenced region: chr7:142,577,530–142,577,732) and the (CA)n repeat of
Igf2 (GRCm38/mm10 chr 7:142,652,936–142,652,973; sequenced region: chr7:142,652,821–
142,653,091) were analysed as described by Pedone et al, [45]. The forward primer of Igf2was
labelled with FAM and the PCR products were run on the ABI 3130XL fluorescent capillary
system (Applied Biosystems Italy, Milan).
DNA methylation analysis
The methylation status of cytosines in gDNA was determined by bisulphite treatment followed
by pyrosequencing or cloning and sequencing. About 1 μg of genomic DNA was treated by
sodium bisulphite using the Epitech Kit (Qiagen Italy, Milan), according to the manufacturer’s
instructions. For the pyrosequencing, converted DNA was amplified with primers of which
the reverse primer was biotinylated. The PCR products were run on the PyroMark Q24 plat-
form, using PyromMark Gold Q96 Reagent [Qiagen Italy, Milan]. For bisulphite cloning and
sequencing, converted DNA was amplified, the PCR products were cloned in Topo pCR2.1
vector (Topo-TA cloning kit, Termo Fisher Scientific Italy, Milan) and the clones were
sequenced by Sanger method at Microtech Sequencing Core (Naples, Italy). Primers and PCR
conditions are reported in S1 Table.
Statistical analyses
Unless otherwise indicated, data are expressed as the mean ± standard error of the mean
(SEM). The significance of the difference between two groups (KI and wildtype) was deter-
mined with a two-tailed Student’s t-test with two-sample unequal variance. The number of
samples, animals, biological or technical replicates are indicated in the respective figure leg-
ends. Differences with P-values 0.05 were considered significant.
Supporting information
S1 Fig. (Related to Fig 2). Phenotypic characterization of H19hIC1/+ mice. Box plots of birth
weights (A), growth charts (B), and box plots of organ weights (C) ofH19hIC1/+ mice and
H19+/+ littermates. Box plots in (A) and (C) and growth chart in (B) are depicted as in Fig 2.
Values in brackets indicate the number of animals derived from two (A and C) or three (B)
litters that was used for this study. P = NS: Not Significant. Bars represent the mean ± SEM.
(TIF)
S2 Fig. (Related to Fig 3). Analysis of H19 and Igf2 expression in H19hIC1/+ newborn mice.
(A) Allele-specific expression ofH19 and Igf2 analysed as in Fig 3. (B) Histograms of totalH19
and Igf2 expression in three different neonatal organs ofH19hIC1/+ andH19+/+ littermates. The
animals used for this study derived from two litters.
(TIF)
S3 Fig. Stability of IC1 methylation of H19hIC1Δ2.2/+ mice after consecutive passages
through the female germline. Percent methylation measured by pyrosequencing at two
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CTCF target sites (CTS1 and CTS6) in three different organs collected fromH19hIC1Δ2.2/+ mice
derived from three successive generations of breedingH19hIC1Δ2.2/+ females with +/+ males (II,
III and IV generations). Black symbols: KI mice, white symbols: +/+ mice. Tested mice derive
from two litters in each generation (n = 6, 4, 5). See legend to Fig 4 for more details.
(TIF)
S4 Fig. Analysis of H19 and Igf2 expression in H19+/hIC1Δ2.2 and H19+/hIC1 mice at E15.5.
(A-B) Histograms of totalH19 and Igf2 expression in embryo body and placenta of
H19+/hIC1Δ2.2 (A) andH19+/hIC1 (B) mice at E15.5 compared to relative H19+/+ littermates,
analysed as in Fig 3. (C-D) Allele-specific expression ofH19 and Igf2 in in embryo body and
placenta ofH19+/hIC1Δ2.2 (C) andH19+/hIC1 (D) mice at E15.5. Dots indicate the percent expres-
sion of the paternal allele in each individual sample. The animals used for this study derived
from two litters.
(TIF)
S5 Fig. IC1 methylation in H19+/hIC1Δ2.2 mice. (A) See legend to Fig 4A. (B) Percent methyla-
tion measured by pyrosequencing at CTS1 and CTS6 in three different organs collected from
H19+/hIC1Δ2.2mice at birth (left panel). The endogenous mIC1 was analysed as in Fig 3. Each
histogram represents the methylation mean value of 5 (CTS1 and mIC1) or 6 (CTS6) CpGs,
tested inH19+/hIC1Δ2.2.2 (n = 8) andH19+/+ (n = 5) mice derived from three litters. Bars repre-
sent the mean ± SEM. (C) IC1 methylation analysed by bisulphite treatment followed by clon-
ing and sequencing in the tongue of aH19+/hIC1Δ2.2 mouse. See legend to Fig 3 for more
details.
(TIF)
S6 Fig. Stability of hIC1Δ2.2 methylation through the male germline and after the passage
from female to male germline. (A) Percent methylation measured by pyrosequencing at two
CTCF target sites (CTS1 and CTS6) in three different organs collected fromH19+/hIC1Δ2.2 mice
of three successive generations of breedingH19+/hIC1Δ2.2males with +/+ females (II, III and IV
generations of the pedigree). (B) Stable methylation phenotype in mice derived from breeding
ofH19hIC1Δ2.2/+ female with +/+ male (II generation) and H19hIC1Δ2.2/+male with +/+ female
(III generation). Tested mice derive from two litters in each generation: in (A)H19+/hIC1Δ2.2
(n = 5, 5, 6); in (B) H19hIC1Δ2.2/+ (n = 6) andH19+/hIC1Δ2.2 (n = 6). See legend to Fig 4 for more
details.
(TIF)
S7 Fig. Absence of kidneys asymmetry in H19hIC1/+ mice. Weight ratio of the heavier to the
lighter kidney inH19hIC1/+ and their +/+ littermates derived from two litters at 12 weeks-old
mice.
(TIF)
S1 Table. Primers and PCR conditions of the pyosequencing assay. hIC1-:primers to
amplify the human IC1 of the knock-in. mIC-: primers to amplify the mouse IC1 and IC2.
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24. Berland S, Appelbäck M, Bruland O, Beygo J, Buiting K, Mackay DJ, Karen Temple I, Houge G (2013)
Evidence for anticipation in Beckwith-Wiedemann syndrome. Eur J Hum Genet 21: 1344–1348 https://
doi.org/10.1038/ejhg.2013.71 PMID: 23572028
25. Abi Habib W, Azzi S, Brioude F, Steunou V, Thibaud N, Das Neves C, Le Jule M, Chantot-Bastaraud S,
Keren B, Lyonnet S, Michot C, Rossi M, Pasquier L, Gicquel C, Rossignol S, Le Bouc Y, Netchine I
(2014) Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2
binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome.
Hum Mol Genet 23: 5763–5773 https://doi.org/10.1093/hmg/ddu290 PMID: 24916376
26. Abi Habib W, Brioude F, Azzi S, Salem J, Das Neves C, Personnier C, Chantot-Bastaraud S, Keren B,
Le Bouc Y, Harbison MD, Netchine I (2017) 11p15 ICR1 Partial Deletions Associated with IGF2/H19
DMR Hypomethylation and Silver-Russell Syndrome. Hum Mutat 38: 105–111 https://doi.org/10.1002/
humu.23131 PMID: 27701793
27. Drewell RA, Brenton JD, Ainscough JF, Barton SC, Hilton KJ, Arney KL, Dandolo L, Surani MA (2000)
Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic
switch. Development 127: 3419–3428 PMID: 10903168
28. Thorvaldsen JL, Mann MR, Nwoko O, Duran KL, Bartolomei MS (2002) Analysis of sequence upstream
of the endogenous H19 gene reveals elements both essential and dispensable for imprinting. Mol Cell
Biol 22: 2450–2462. https://doi.org/10.1128/MCB.22.8.2450-2462.2002 PMID: 11909940
29. Schoenherr CJ, Levorse JM, Tilghman SM (2003) CTCF maintains differential methylation at the Igf2/
H19 locus. Nat Genet 33: 66–69 https://doi.org/10.1038/ng1057 PMID: 12461525
A transgenic mouse model of BWS and SRS
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007243 February 22, 2018 22 / 23
30. Pant V, Mariano P, Kanduri C, Mattsson A, Lobanenkov V, Heuchel R, Ohlsson R (2003) The nucleo-
tides responsible for the direct physical contact between the chromatin insulator protein CTCF and the
H19 imprinting control region manifest parent of origin-specific long-distance insulation and methyla-
tion-free domains. Genes Dev 17: 586–590 https://doi.org/10.1101/gad.254903 PMID: 12629040
31. Pant V, Kurukuti S, Pugacheva E, Shamsuddin S, Mariano P, Renkawitz R, Klenova E, Lobanenkov V,
Ohlsson R (2004) Mutation of a single CTCF target site within the H19 imprinting control region leads to
loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance. Mol Cell
Biol 24: 3497–3504 https://doi.org/10.1128/MCB.24.8.3497-3504.2004 PMID: 15060168
32. Engel N, West AG, Felsenfeld G, Bartolomei M (2004) Antagonist between DNA hypermethylation and
enhancer-blocking activity at the H19 DMD is uncovered by CpGg mutations. Nat Genet 36: 883–888
https://doi.org/10.1038/ng1399 PMID: 15273688
33. Engel N, Thorvaldsen JL, Bartolomei MS (2006) CTCF binding sites promote transcription initiation and
prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus. Hum Mol Genet 15:
2945–2954 https://doi.org/10.1093/hmg/ddl237 PMID: 16928784
34. Thorvaldsen JL, Fedoriw AM, Nguyen S, Bartolomei MS (2006) Developmental profile of H19 differen-
tially methylated domain (DMD) deletion alleles reveals multiple roles of the DMD in regulating allelic
expression and DNA methylation at the imprinted H19/Igf2 locus. Mol Cell Biol. 26: 1245–1258 https://
doi.org/10.1128/MCB.26.4.1245-1258.2006 PMID: 16449639
35. Ideraabdullah FY, Thorvaldsen JL, Myers JA, Bartolomei MS (2014) Tissue-specific insulator function
at H19/Igf2 revealed by deletions at the imprinting control region. Hum Mol Genet 23: 6246–6259
https://doi.org/10.1093/hmg/ddu344 PMID: 24990148
36. Beygo J, Citro V, Sparago A, De Crescenzo A, Cerrato F, Heitmann M, Rademacher K, Guala A,
Enklaar T, Anichini C, Cirillo Silengo M, Graf N, Prawitt D, Vittoria Cubellis M, Horsthemke B, Buiting K,
Riccio A (2013) The molecular function and clinical phenotype of partial deletions of the IGF2/H19
imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites.
Hum Mol Genet 22: 544–57 https://doi.org/10.1093/hmg/dds465 PMID: 23118352
37. Hur SK, Freschi A, Ideraabdullah F, Thorvaldsen JL, Luense LJ, Weller AH, Berger SL, Cerrato F, Ric-
cio A, Bartolomei MS (2016) Humanized H19/Igf2 locus reveals diverged imprinting mechanism
between mouse and human and reflects Silver-Russell syndrome phenotypes. Proc Natl Acad Sci USA
113: 10938–10943 https://doi.org/10.1073/pnas.1603066113 PMID: 27621468
38. Wakeling EL, Brioude F, Lokulo-Sodipe O, O’Connell SM, Salem J, Bliek J, Canton AP, Chrzanowska
KH, Davies JH, Dias RP, Dubern B, Elbracht M, Giabicani E, Grimberg A, Grønskov K, Hokken-Koelega
AC, Jorge AA, Kagami M, Linglart A et al, (2017) Diagnosis and management of Silver-Russell syn-
drome: first international consensus statement. Nat Rev Endocrinol 13: 105–124 https://doi.org/10.
1038/nrendo.2016.138 PMID: 27585961
39. Mussa A, Russo S, Larizza L, Riccio A, Ferrero GB (2016) (Epi)genotype-phenotype correlations in
Beckwith-Wiedemann syndrome: a paradigm for genomic medicine. Clin Genet 89: 403–415
40. Mussa A, Peruzzi L, Chiesa N, De Crescenzo A, Russo S, Melis D, Tarani L, Baldassarre G, Larizza L,
Riccio A, Silengo M, Ferrero GB (2012) Nephrological findings and genotype-phenotype correlation in
Beckwith-Wiedemann syndrome. Pediatr Nephrol 27: 397–406 https://doi.org/10.1007/s00467-011-
2009-4 PMID: 22015620
41. Ginart P, Kalish JM, Jiang CL, Yu AC, Bartolomei MS, Raj A (2016) isualizing allele-specific expression
in single cells reveals epigenetic mosaicism in an H19 loss-of-imprinting mutant. Genes Dev 30: 567–
578 https://doi.org/10.1101/gad.275958.115 PMID: 26944681
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